If you are ill of ALS, you may want to read this little guide (in French) on home adjustments and possible nutritional supplements.
A document calling for creating a TDP-43 gene therapy, which is modeled after gene therapy for spinal muscular atrophy.
Certain dewormers for humans, or other products such as dichloroacetic acid, were withdrawn from the market immediately after they were found to have anti-cancer properties. What about Fenbendazole? An article from Nature enlightens us.
Unlike many diseases, there are no official ALS biomarkers. This software prototype shows how to use certain biomarkers to maximize chances of survival to ALS.
Patients with amyotrophic lateral sclerosis (ALS) experience progressive limb weakness, muscle atrophy, and dysphagia, making them vulnerable to insufficient energy intake. Half of ALS patients suffer from hyper-metabolism. In 2014 Edward J Kasarskis and his colleagues developed equations to estimate energy requirements of ALS patients. Here is the link to calculator using those formulas.